Resveratrol Supplementation Reduces Pain and Inflammation in Knee Osteoarthritis Patients Treated with Meloxicam: A Randomized Placebo-Controlled Study

Marouf BH, Hussain SA, Ali ZS, Ahmmad RS · Journal of Medicinal Food

Companion paper of the same trial reporting VAS-100 pain and serum inflammatory markers (IL-1beta, IL-6, TNF-alpha, CRP, C3/C4); the abstract reports significant reductions versus placebo. Written from the abstract; the effect sizes have not been checked against the paper.

Population

The same 110-patient Sulaimani cohort as pmid-30233159 (companion publication)

Intervention

Resveratrol 500 mg once daily for 90 days, added to meloxicam 15 mg/day

Comparator

Placebo (both arms on meloxicam)

Limitations

Same cohort, arms and limitations as pmid-30233159 — this is not an independent trial. Its between-group numbers have not been checked against the paper.